Curanex Pharmaceuticals IncCURX
Price (close)
$4.74
Market cap
$7.4M
P/E
—
Revenue (TTM)
—
Net income
-$10.5M
Dividend yield
—
1-year total return
-65.1%
Net margin
—
Revenue growth
—
Debt / equity
—
What Curanex Pharmaceuticals Inc does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net income | — | -$361,506 | -$4.2M |
More on CURX.
- Curanex Pharmaceuticals Inc summary
- Curanex Pharmaceuticals Inc financial statements
- Curanex Pharmaceuticals Inc key metrics
- Curanex Pharmaceuticals Inc health scores and style box
- Curanex Pharmaceuticals Inc earnings
- Curanex Pharmaceuticals Inc dividends
- Curanex Pharmaceuticals Inc valuation
- Curanex Pharmaceuticals Inc ownership and insiders
- Curanex Pharmaceuticals Inc peers
Figures from Curanex Pharmaceuticals Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.